The intellectual property license between Cellmid and Lyramid has been amended from
a royalty free arrangement to 4% royalty on sales of products developed as a result of
the licensed midkine intellectual property and 8% royalty on sublicense revenue. The term
of the license is five years after all patent rights expire, whether current patents or patents
arising out of existing midkine intellectual property.
What does that mean to you Dentie/ Ozjin
- Forums
- ASX - By Stock
- Ann: Appendix 4D and Half Year Report
The intellectual property license between Cellmid and Lyramid...
-
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online